L-K6L9 TFA

L-K6L9 is a synthetic cytolytic peptide active against both androgen-dependent and independent prostate cancer cell lines, with LC50 values ranging from 4 to 6 μM. It also exhibits cytotoxicity in non-cancerous fibroblasts and induces hemolysis at higher concentrations. This peptide is a research tool for studying membrane-disrupting mechanisms in oncology and toxicology.